These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2374216)

  • 1. Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures.
    Bloom DA; Knechtel JM; McGuire EJ
    J Urol; 1990 Aug; 144(2 Pt 2):430-3; discussion 443-4. PubMed ID: 2374216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urethral dilation as treatment for neurogenic bladder.
    Kiddoo DA; Canning DA; Snyder HM; Carr MC
    J Urol; 2006 Oct; 176(4 Pt 2):1831-3; discussion 1834. PubMed ID: 16945663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External urethral sphincter dilation for the management of high risk myelomeningocele: 15-year experience.
    Park JM; McGuire EJ; Koo HP; Schwartz AC; Garwood CK; Bloom DA
    J Urol; 2001 Jun; 165(6 Pt 2):2383-8. PubMed ID: 11371982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder compliance in meningomyelocele children.
    Ghoniem GM; Bloom DA; McGuire EJ; Stewart KL
    J Urol; 1989 Jun; 141(6):1404-6. PubMed ID: 2724439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder-sphincter dysfunction in myelomeningocele.
    van Gool JD; Dik P; de Jong TP
    Eur J Pediatr; 2001 Jul; 160(7):414-20. PubMed ID: 11475578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of neurogenic bladder dysfunction secondary to myelomeningocele.
    Castro-Gago M; Novo I; Cimadevila A; Peña J; Rodriguez-Núñez A; Marqués'-Queimadelos A
    Eur J Pediatr; 1990 Nov; 150(1):62-5. PubMed ID: 2079080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravesical and intraurethral pressure studies: significance for the prognosis and the treatment of children with myelomeningocele (author's transl)].
    Bödeker J; Nagel R
    Urologe A; 1977 Sep; 16(5):258-66. PubMed ID: 906189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of neurogenic bladder secondary to myelomeningocele based on the urodynamic status with intermittent catheterization associated with drugs. Preliminary results].
    Castro-Gago M; Marqués-Queimadelos A; Cimadevila A; Novo I; Peña J
    An Esp Pediatr; 1987 Feb; 26(2):103-6. PubMed ID: 3565950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urodynamic examination of the lower urinary tract in children with normal and congenital neurogenic bladder.
    Thorup J
    Scand J Urol Nephrol Suppl; 1994; 158():1-59. PubMed ID: 7817158
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of urethral dilation in managing pediatric neurogenic bladder dysfunction.
    Wan J
    Curr Urol Rep; 2009 Mar; 10(2):153-8. PubMed ID: 19239821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporary perineal urethrostomy for external sphincter dilation in a male patient with high risk myelomeningocele.
    Miller DC; Bloom DA; McGuire EJ; Park JM
    J Urol; 2003 Oct; 170(4 Pt 2):1606-8; discussion 1608-9. PubMed ID: 14501673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bladder pressure management system for myelodysplasia--clinical outcome.
    Wang SC; McGuire EJ; Bloom DA
    J Urol; 1988 Dec; 140(6):1499-502. PubMed ID: 3193522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic bladder dysfunction.
    Bauer SB
    Pediatr Clin North Am; 1987 Oct; 34(5):1121-32. PubMed ID: 3658504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myelomeningocele in children and adolescents. Clean intermittent catheterization].
    Sommer FF; Hagelsteen JH; Kalvik AM
    Tidsskr Nor Laegeforen; 1986 Aug; 106(24):1957-9. PubMed ID: 3775715
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele.
    Korzeniecka-Kozerska A; Porowski T; Michaluk-Skutnik J; Wasilewska A; Płoński G
    Scand J Urol; 2013 Oct; 47(5):411-7. PubMed ID: 23301927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prophylactic use of clean intermittent catheterization in the treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction.
    Geraniotis E; Koff SA; Enrile B
    J Urol; 1988 Jan; 139(1):85-6. PubMed ID: 3336111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of toxin-A Botulinum for treating intractable bladder hyperactivity in children affected by neuropathic bladder secondary to myelomeningocele: an alternative to enterocystoplasty].
    Marte A; Vessella A; Cautiero P; Romano M; Borrelli M; Noviello C; Del Gado R; Parmeggiani P
    Minerva Pediatr; 2005 Feb; 57(1):35-40. PubMed ID: 15791200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele.
    Horst M; Weber DM; Bodmer C; Gobet R
    Neurourol Urodyn; 2011 Nov; 30(8):1546-9. PubMed ID: 21674597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term indwelling urethral catheterisation for congenital neuropathic bladder.
    Rickwood AM; Philp NH; Thomas DG
    Arch Dis Child; 1983 Apr; 58(4):310-4. PubMed ID: 6847235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.